Search

everythinglearnresearchcommunity

for

Search:↓

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Necrostatin-1s can promote hair growth and may help treat hair loss.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Basonuclin 1 (BNC1) helps skin cells multiply and move, which is crucial for wound healing.

Microneedle patches with alpha-arbutin and resveratrol can effectively reduce skin pigmentation without irritation.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

A medicine company has recalled a drug because it contained an unlisted blood pressure medication.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Spanlastic formulations improve rivaroxaban's oral anticoagulation efficiency.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

The study concluded that specific proteins are necessary to maintain the structure that holds epithelial cells tightly together.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Vitamin D protects skin cells from damage caused by captopril.

These drugs raise prostaglandin-like material in dog blood, possibly causing blood vessel widening.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

FOL-026 peptide may help hair growth and cardiovascular health by improving blood flow and cell functions.